Endocrinology and Metabolic Disorders

Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid arthritis. Cumberland pharmaceuticals pharma company focusing on acquiring and commercializing prescription products has gained access to the injection from Nordic Group two years back. Nordic’s injectable methotrexate products manufactured to cure diseases, like active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis, have already been approved in Europe in 2016. With approval from the US FDA, Cumberland will gain the right to commercialize the product in the US. As ...